Pictet Asset Management (UK)’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-994,476
| Closed | -$3.4M | – | 1808 |
|
|
2020
Q4 | $3.4M | Sell |
994,476
-57,900
| -6% | -$198K | ﹤0.01% | 873 |
|
|
2020
Q3 | $1.52M | Sell |
1,052,376
-51,900
| -5% | -$74.7K | ﹤0.01% | 921 |
|
|
2020
Q2 | $2.2M | Sell |
1,104,276
-97,800
| -8% | -$195K | ﹤0.01% | 851 |
|
|
2020
Q1 | $2.34M | Buy |
1,202,076
+502,700
| +72% | +$980K | 0.01% | 821 |
|
|
2019
Q4 | $2.9M | Sell |
699,376
-30,500
| -4% | -$127K | 0.01% | 856 |
|
|
2019
Q3 | $2.2M | Buy |
729,876
+64,100
| +10% | +$193K | ﹤0.01% | 835 |
|
|
2019
Q2 | $4.19M | Buy |
665,776
+78,926
| +13% | +$496K | 0.01% | 727 |
|
|
2019
Q1 | $3.26M | Buy |
586,850
+175,400
| +43% | +$975K | 0.01% | 766 |
|
|
2018
Q4 | $2.73K | Buy |
411,450
+142,200
| +53% | +$944 | 0.01% | 775 |
|
|
2018
Q3 | $2.87M | Sell |
269,250
-24,400
| -8% | -$260K | 0.01% | 835 |
|
|
2018
Q2 | $3.52M | Sell |
293,650
-110,000
| -27% | -$1.32M | 0.01% | 729 |
|
|
2018
Q1 | $3.46M | Buy |
403,650
+143,100
| +55% | +$1.23M | 0.01% | 723 |
|
|
2017
Q4 | $2.57M | Buy |
260,550
+185,300
| +246% | +$1.83M | 0.01% | 782 |
|
|
2017
Q3 | $925K | Buy |
75,250
+7,300
| +11% | +$89.7K | ﹤0.01% | 835 |
|
|
2017
Q2 | $941K | Buy |
67,950
+6,400
| +10% | +$88.6K | ﹤0.01% | 823 |
|
|
2017
Q1 | $883K | Buy |
61,550
+6,800
| +12% | +$97.6K | ﹤0.01% | 822 |
|
|
2016
Q4 | $757K | Buy |
+54,750
| New | +$757K | ﹤0.01% | 812 |
|